|
US1354753A
(en)
|
1919-02-11 |
1920-10-05 |
E M Lannes |
Portable building
|
|
US4331803A
(en)
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
|
US4474768A
(en)
|
1982-07-19 |
1984-10-02 |
Pfizer Inc. |
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
|
|
US4742049A
(en)
|
1986-06-04 |
1988-05-03 |
Abbott Laboratories |
Semisynthetic erythromycin antibiotics
|
|
KR960000434B1
(ko)
*
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
|
IL114589A
(en)
|
1990-11-21 |
1999-12-22 |
Roussel Uclaf |
Intermediates for the preparation of erythromycin derivatives
|
|
US5985844A
(en)
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
|
US5527780A
(en)
|
1992-11-05 |
1996-06-18 |
Roussel Uclaf |
Erythromycin derivatives
|
|
FR2697524B1
(fr)
|
1992-11-05 |
1994-12-23 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
FR2718450B1
(fr)
|
1994-04-08 |
1997-01-10 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
FR2719587B1
(fr)
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
FR2739620B1
(fr)
|
1995-10-09 |
1997-12-19 |
Roussel Uclaf |
Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
|
|
US6274715B1
(en)
|
1995-11-08 |
2001-08-14 |
Abbott Laboratories |
Tricyclic erythromycin derivatives
|
|
FR2742757B1
(fr)
|
1995-12-22 |
1998-01-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
FR2745290B1
(fr)
|
1996-02-28 |
1998-04-03 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
US5719272A
(en)
*
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
|
DE69733723T2
(de)
|
1996-09-04 |
2006-04-20 |
Abbott Laboratories, Abbott Park |
6-o-Substituierte Ketoliden mit antibakteriellen Wirkung
|
|
US6407074B1
(en)
|
1997-06-11 |
2002-06-18 |
Pfizer Inc |
C-4″-substituted macrolide derivatives
|
|
HN1998000086A
(es)
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
|
CZ9904388A3
(cs)
|
1997-06-11 |
2002-10-16 |
Pfizer Products Inc. |
9-Oximové deriváty erythromycinu
|
|
HN1998000159A
(es)
|
1997-10-29 |
1999-02-09 |
Monsanto Co |
Derivados de 9- amino - 3 ceto eritromicina
|
|
IL135792A0
(en)
|
1997-12-01 |
2001-05-20 |
Abbott Lab |
6-o-alkyl derivatives of erythronolide b
|
|
FR2777282B1
(fr)
|
1998-04-08 |
2001-04-20 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
|
|
US6387885B1
(en)
|
1998-08-26 |
2002-05-14 |
Abbott Laboratories |
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
|
|
US6020521A
(en)
|
1998-08-26 |
2000-02-01 |
Abbott Laboratories |
Macrolide LHRH antagonists
|
|
FR2785612A1
(fr)
|
1998-11-10 |
2000-05-12 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
KR100317907B1
(ko)
|
1998-11-24 |
2001-12-24 |
김 완 주 |
신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
|
|
FR2786188B1
(fr)
|
1998-11-24 |
2002-10-31 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
|
|
TR200102129T2
(tr)
|
1998-12-10 |
2002-01-21 |
Pfizer Products Inc. |
Karbamat ve karbazat ketolid antibiyotikleri.
|
|
CA2359708C
(en)
|
1999-01-27 |
2005-10-25 |
Pfizer Products Inc. |
Ketolide antibiotics
|
|
CA2292359C
(en)
|
1999-01-28 |
2004-09-28 |
Pfizer Products Inc. |
Novel azalides and methods of making same
|
|
JP2000351794A
(ja)
|
1999-04-08 |
2000-12-19 |
Hokuriku Seiyaku Co Ltd |
エリスロマイシン誘導体
|
|
AR023264A1
(es)
*
|
1999-04-08 |
2002-09-04 |
Hokuriku Pharmaceutical |
Derivados de eritromicina
|
|
IL145976A0
(en)
|
1999-04-16 |
2002-07-25 |
Ortho Mcneil Pharm Inc |
Ketolide antibacterials
|
|
ID30547A
(id)
|
1999-04-16 |
2001-12-20 |
Kosan Biosciences Inc |
Zat anti-infeksi makrolida
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6420535B1
(en)
|
1999-06-07 |
2002-07-16 |
Abbott Laboratories |
6-O-carbamate ketolide derivatives
|
|
US6437106B1
(en)
|
1999-06-24 |
2002-08-20 |
Abbott Laboratories |
Process for preparing 6-o-substituted erythromycin derivatives
|
|
WO2001010878A1
(fr)
|
1999-08-06 |
2001-02-15 |
Taisho Pharmaceutical Co., Ltd. |
Derives d'erythromycine a
|
|
KR100336447B1
(ko)
|
1999-11-24 |
2002-05-15 |
민경윤 |
클라리스로마이신의 개선된 제조방법
|
|
JP2001261694A
(ja)
|
2000-03-06 |
2001-09-26 |
Pfizer Prod Inc |
ケトライド抗生物質
|
|
ATE297941T1
(de)
*
|
2000-03-15 |
2005-07-15 |
Hanmi Pharm Ind Co Ltd |
Verfahren zur herstellung von einer kristallinen form ii von clarythromycin
|
|
NZ523693A
(en)
|
2000-07-10 |
2004-08-27 |
Chiron Corp |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
|
US20020115621A1
(en)
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
|
GB0031312D0
(en)
|
2000-12-21 |
2001-02-07 |
Glaxo Group Ltd |
Macrolides
|
|
PT1320355E
(pt)
|
2001-05-18 |
2006-08-31 |
Chiron Corp |
Sistema para administracao de uma formulacao de tobramicina
|
|
WO2003004509A2
(en)
*
|
2001-07-03 |
2003-01-16 |
Chiron Corporation |
C12 modified erythromycin macrolides and ketolides having antibacterial activity
|
|
US20030176327A1
(en)
|
2001-10-25 |
2003-09-18 |
Cassell Gail Houston |
Antibiotics for treating biohazardous bacterial agents
|
|
BR0307898A
(pt)
|
2002-02-22 |
2004-12-07 |
Pharmacia Corp |
Formulações de droga antibiótica oftálmica contendo um composto de ciclodextrina e cloreto de cetil piridìnio
|
|
AU2003240482B2
(en)
|
2002-05-30 |
2009-03-12 |
The Scripps Research Institute |
Copper-catalysed ligation of azides and acetylenes
|
|
EP1553954A4
(en)
|
2002-06-17 |
2009-12-23 |
Epigenesis Pharmaceuticals Llc |
DIHYDRATE DEHYDROEPIANDROSTERONE AND METHOD FOR THE TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE LUNG DISEASE, COMPOSITIONS THEREOF
|
|
AR043050A1
(es)
|
2002-09-26 |
2005-07-13 |
Rib X Pharmaceuticals Inc |
Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
|
|
ITMI20022292A1
(it)
|
2002-10-29 |
2004-04-30 |
Zambon Spa |
9a-azalidi ad attivita' antiinfiammatoria.
|
|
ES2552682T3
(es)
|
2003-03-10 |
2015-12-01 |
Merck Sharp & Dohme Corp. |
Agentes antibacterianos novedosos
|
|
US7332476B2
(en)
|
2003-04-25 |
2008-02-19 |
Novartis Ag |
Pyridyl substituted ketolide antibiotics
|
|
US7163924B2
(en)
|
2003-04-25 |
2007-01-16 |
Chiron Corporation |
Ketolide derivatives
|
|
SI1628989T1
(sl)
*
|
2003-05-13 |
2007-06-30 |
Glaxo Group Ltd |
Nove cikliäśne spojine s 14 in 15 obroäśnimi äśleni
|
|
WO2005007143A2
(en)
|
2003-07-14 |
2005-01-27 |
The Board Of Trustees Of The University Of Illinois |
Use of makrolides and ketolides for the treatment of tuberculosis
|
|
US7457520B2
(en)
|
2003-07-24 |
2008-11-25 |
Time Warner Cable, Inc. |
Technique for providing a virtual digital video recorder service through a communications network
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US20060116336A1
(en)
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
|
SI1742957T1
(sl)
|
2004-04-28 |
2008-04-30 |
Alembic Ltd |
Postopek za pripravo telitromicina
|
|
BRPI0510328A
(pt)
*
|
2004-05-06 |
2007-10-23 |
Glaxosmithkline Zagreb |
macrolìdeos ligados a éster úteis para o tratamento de infecções microbianas
|
|
JP2008508322A
(ja)
|
2004-07-28 |
2008-03-21 |
ランバクシー ラボラトリーズ リミテッド |
抗菌剤としてのケトライド誘導体
|
|
GB0424959D0
(en)
*
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0424958D0
(en)
*
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
|
CN2756842Y
(zh)
*
|
2004-11-12 |
2006-02-08 |
胡济荣 |
沙滩车用一体化发动机
|
|
EP1841437B1
(en)
|
2005-01-14 |
2009-04-29 |
GlaxoSmithKline istrazivacki centar Zagreb d.o.o. |
9a-carbamoyl and thiocarbamoyl azalides with antimalarial activity
|
|
EP1835921B1
(en)
|
2005-01-14 |
2010-08-18 |
GlaxoSmithKline istrazivacki centar Zagreb d.o.o. |
9a-carbamoyl-y-aminopropyl- and 9a-thiocarbamoyl-y-aminopropyl-azalides with antimalarial activity
|
|
CA2614412A1
(en)
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
|
WO2007059307A2
(en)
|
2005-11-15 |
2007-05-24 |
Teva Pharmaceutical Industries Ltd. |
Crystalline and amorphous forms of telithromycin
|
|
US20090075916A1
(en)
|
2005-11-23 |
2009-03-19 |
Upadhyay Dilip J |
Use of Macrolide Derivatives for Treating Acne
|
|
DOP2006000268A
(es)
|
2005-12-22 |
2007-07-31 |
Pfizer Prod Inc |
Agentes antibacterianos
|
|
CN101045063B
(zh)
|
2006-03-28 |
2011-01-26 |
广州朗圣药业有限公司 |
注射用克拉霉素水溶性制剂
|
|
WO2007143507A2
(en)
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
CN101129383B
(zh)
|
2006-08-25 |
2014-04-02 |
天津和美生物技术有限公司 |
含氨基糖苷类抗生素的抗生素复方
|
|
US7742562B2
(en)
*
|
2007-06-27 |
2010-06-22 |
Accuray Incorporated |
Lower-torso assembly of a treatment couch useable in an X-ray environment
|
|
CN103860469A
(zh)
*
|
2007-10-23 |
2014-06-18 |
英斯麦德公司 |
脂质体万古霉素制剂
|
|
CN105732745A
(zh)
|
2007-10-25 |
2016-07-06 |
森普拉制药公司 |
大环内酯类抗菌剂的制备方法
|
|
AU2009308182B2
(en)
|
2008-10-24 |
2016-05-19 |
Cempra Pharmaceuticals, Inc. |
Biodefenses using triazole-containing macrolides
|
|
CA2767614C
(en)
|
2009-07-13 |
2019-01-15 |
Cempra Pharmaceuticals Inc. |
Fusidic acid dosing regimens for treatment of bacterial infections
|
|
US9480679B2
(en)
|
2009-09-10 |
2016-11-01 |
Cempra Pharmaceuticals, Inc. |
Methods for treating malaria, tuberculosis and MAC diseases
|
|
PL2544537T3
(pl)
|
2010-03-10 |
2017-10-31 |
Cempra Pharmaceuticals Inc |
Pozajelitowe preparaty antybiotyków makrolidowych
|
|
DK2550286T3
(en)
|
2010-03-22 |
2016-02-29 |
Cempra Pharmaceuticals Inc |
CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
|
|
CN105198944B
(zh)
|
2010-05-20 |
2018-06-01 |
森普拉制药公司 |
制备大环内酯和酮内酯及其中间体的方法
|
|
US8247394B2
(en)
|
2010-06-02 |
2012-08-21 |
Cempra Pharmaceuticals Inc. |
Methods of treating urethritis and related infections using fusidic acid
|
|
US20130164351A1
(en)
|
2010-08-30 |
2013-06-27 |
Cempra Pharmaceuticals Inc. |
Methods of treating bacterial infections through pulmonary delivery of fusidic acid
|
|
EP2613630A4
(en)
|
2010-09-10 |
2014-01-15 |
Cempra Pharmaceuticals Inc |
HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
|
|
US20140088062A1
(en)
|
2011-05-23 |
2014-03-27 |
Cem-102 Pharmaceuticals, Inc. |
Compositions comprising fusidic acid and packages therefor
|
|
MX2014011537A
(es)
|
2012-03-27 |
2015-02-10 |
Cempra Pharmaceuticals Inc |
Formulaciones parenterales para la administracion de antibioticos macrolidos.
|
|
HK1217665A1
(zh)
|
2013-03-14 |
2017-01-20 |
森普拉制药公司 |
用於治療呼吸道疾病的方法及其製劑
|
|
RU2015138797A
(ru)
|
2013-03-15 |
2017-04-24 |
Семпра Фармасьютикалс, Инк. |
Конвергентные способы получения макролидных антибактериальных агентов
|